Literature DB >> 6808809

Intracranial hypertension and brain oedema in albino rabbits. Part 3: Effect of acute simultaneous diuretic and barbiturate therapy.

C H Millson, H E James, H M Shapiro, R Laurin.   

Abstract

Increased intracranial pressure due to brain oedema was produced in albino rabbits by combining a cryogenic lesion in the left hemisphere with the intraperitoneal administration of 6-aminonicotinamide (cytotoxic agent). The following parameters were assessed: intracranial pressure (ICP), systolic arterial pressure (SAP), central venous pressure (CVP), EEG, brain water and electrolyte content, gross pathology, and blood brain barrier integrity. Acute therapy to reduce ICP was performed by administering a bolus of mannitol (1 gm/kg) and 30 minutes later, also in bolus, frusemide (5 mg/kg). Immediately following the administration of mannitol an infusion of pentobarbitone was commenced; this was continued for one hour so that a total of 10 mg/kg was administered. There was a 50% reduction of ICP at one hour from initiation of treatment. The brains of the animals were extracted immediately upon cessation of therapy (pentobarbitone) and they revealed a significant reduction of water content for the right, uninjured, hemisphere only, when compared to controls; a slight but not significant reduction of the brain sodium and potassium was noted in both hemispheres. There was no change noted in the gross pathology and extent of blood brain barrier breakdown. In all animals epinephrine infusion had to be administered for between 20 and 30 minutes to maintain a SAP over 80 torr. There seems to be no advantage in the simultaneous administration of barbiturates and diuretics for the control of ICP due to brain oedema.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6808809     DOI: 10.1007/BF01743871

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  30 in total

Review 1.  Vasogenic brain oedema. New aspects in its formation, resolution and therapy.

Authors:  H J Reulen
Journal:  Br J Anaesth       Date:  1976-08       Impact factor: 9.166

2.  Extracellular space and electrolyte distribution in cortex and white matter of dog brain in cold induced oedema.

Authors:  A Fenske; M Samii; H J Reulen; O Hey
Journal:  Acta Neurochir (Wien)       Date:  1973       Impact factor: 2.216

3.  Water and electrolyte distribution in gray matter rendered edematous with a metabolic inhibitor.

Authors:  A Baethmann; A Van Harreveld
Journal:  J Neuropathol Exp Neurol       Date:  1973-07       Impact factor: 3.685

4.  Cerebral protection by thiopental during hypoxia.

Authors:  J D Michenfelder; R A Theye
Journal:  Anesthesiology       Date:  1973-11       Impact factor: 7.892

5.  Barbiturate-augmented hypothermia for reduction of persistent intracranial hypertension.

Authors:  H M Shapiro; S R Wyte; J Loeser
Journal:  J Neurosurg       Date:  1974-01       Impact factor: 5.115

6.  Rapid intraoperative reduction of intracranial pressure with thiopentone.

Authors:  H M Shapiro; A Galindo; S R Wyte; A B Harris
Journal:  Br J Anaesth       Date:  1973-10       Impact factor: 9.166

Review 7.  Presidental address. Neuropathological aspects of brain edema.

Authors:  I Klatzo
Journal:  J Neuropathol Exp Neurol       Date:  1967-01       Impact factor: 3.685

8.  Pathophysiology, treatment and outcome following severe head injury in children.

Authors:  D A Bruce; R C Raphaely; A I Goldberg; R A Zimmerman; L T Bilaniuk; L Schut; D E Kuhl
Journal:  Childs Brain       Date:  1979

9.  Intracranial volume--pressure relationships during experimental brain compression in primates. 3. Effect of mannitol and hyperventilation.

Authors:  P Leech; J D Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-10       Impact factor: 10.154

10.  [The effect of the Antimetabolite 6-aminonicotinamide (6-ANA) on the water- and electrolyte content in the brain of rats and its inhibition by niacin].

Authors:  A Baethmann; H J Reulen; W Brendel
Journal:  Z Gesamte Exp Med       Date:  1968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.